In VivoEvaluation of TNF-Alpha in the Lungs of Patients Affected by Sarcoidosis
Open Access
- 19 March 2015
- journal article
- research article
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-7
Abstract
Introduction. Sarcoidosis is a multisystemic granulomatous disorder characterized by multiple noncaseating granulomas involving intrathoracic lymph nodes and lung parenchyma. Recently, the use of anti-tumor necrosis factor alpha (anti-TNFα) agents has been introduced for therapy of chronic and refractory sarcoidosis with controversial results. Infliximab (Remicade) is a chimeric monoclonal antibody (mAb) that recognizes and binds TNFα, neutralizing its biological effects. In the present study,labelled infliximab was used to study the expression of TNFαin sarcoid lesions and to evaluate its role as a predictive marker in response to therapy with Remicade.Material and Methods. A total of 10 patients with newly diagnosed sarcoidosis were enrolled together with 10 control patients affected by rheumatoid arthritis. All patients were studied by planar imaging of the chest with-infliximab at 6 h and 24 h and total body [18F]-FDG PET/CT. Regions of interest were drawn over the lungs and the right arm and target-to-background ratios were analysed for-infliximab. SUVmeanand SUVmaxwere calculated over lungs for FDG.Results and Discussion. Image analysis showed low correlation betweenT/Bratios and BAL results in patients despite positivity at [18F]-FDG PET.Conclusion. In conclusion, patients with newly diagnosed pulmonary sarcoidosis, with FDG-PET and BAL positivity, showed a negative-infliximab scintigraphy.
Keywords
This publication has 37 references indexed in Scilit:
- Off-Label Uses of Anti-TNF Therapy in Three Frequent Disorders: Behçet’s Disease, Sarcoidosis, and Noninfectious UveitisMediators of Inflammation, 2013
- Refractory multisystem sarcoidosis responding to infliximab therapyClinical Rheumatology, 2012
- Clinical outcomes in sarcoidosis after cessation of infliximab treatmentRespirology, 2009
- Sarcoidosis: Clinical Presentation, Diagnosis, and Approach to TreatmentThe American Journal of the Medical Sciences, 2008
- Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imagingNuklearmedizin-Nuclear Medicine, 2008
- Successful treatment with intraarticular infliximab for resistant knee monarthritis in a patient with spondylarthropathy: A role for scintigraphy with 99mTc‐infliximabArthritis & Rheumatism, 2005
- Fluorodeoxyglucose PET Scan in Pulmonary Sarcoidosis during Treatment with Inhaled and Oral CorticosteroidsRespiration, 2003
- 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSeminars in Nuclear Medicine, 2002
- Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1994
- Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosisJournal of Allergy and Clinical Immunology, 1993